Introduction: Bevacizumab Versus Cetuximab in Metastatic Colorectal Cancer
У вашего броузера проблема в совместимости с HTML5
Moderator Johanna Bendell, MD, introduces a panel discussion focuses on the optimization of treatment for patients with metastatic colorectal cancer.
To view more from the discussion, visit http://www.onclive.com/peer-exchange/mcrc-optimization